Animal and Plant Health Inspection Service
12/04/2025 | Press release | Distributed by Public on 12/05/2025 11:56
FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick
Breadcrumb
- Home
- News & Media
- News and Updates
- News Releases
- FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick
FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick
Washington, D.C., December 4, 2025-Today, the U.S. Food and Drug Administration conditionally approved Exzolt Cattle-CA1 (fluralaner) topical solution for the prevention and treatment of New World screwworm (NWS) larval infestations, and the treatment and control of cattle fever tick in beef cattle 2 months of age and older and replacement dairy heifers less than 20 months of age.
#
USDA is an equal opportunity provider, employer, and lender.
Animal and Plant Health Inspection Service published this content on December 04, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 05, 2025 at 17:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]